GLP-1 receptors are abundant throughout the digestive tract, and when activated, they slow gastric emptyingthe rate at which food moves from the stomach into the small intestine
The dose-response relationship in published cases strongly suggests that lower doses carry lower allodynia risk
Precise dosing is critical for obtaining the best results and ensuring safety
"Although evidence supporting the use of these medications for alcohol use disorder is growing, the field still needs to learn considerably more about them, particularly in identifying the underlying mechanisms
Clinical data shows a clear dose-dependent pattern
Whether the use of GLP-1RAs could interfere with this signal, which is being explored for early detection of PDAC, is uncertain 47,48